Immediate Impact
4 from Science/Nature 67 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Sandra Garcet being referenced
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
2020
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sandra Garcet | 1472 | 776 | 462 | 615 | 70 | 2.0k | |
| Andrew Pink | 1408 | 637 | 460 | 741 | 85 | 1.8k | |
| Catherine Maari | 1312 | 843 | 408 | 620 | 64 | 2.3k | |
| Yuichiro Tsunemi | 950 | 519 | 429 | 537 | 90 | 1.8k | |
| Yasutomo Imai | 810 | 1320 | 553 | 482 | 50 | 2.0k | |
| Hideki Fujita | 1305 | 1356 | 549 | 407 | 84 | 2.6k | |
| Wynnis L. Tom | 895 | 408 | 271 | 499 | 56 | 1.6k | |
| Seth Forman | 1756 | 357 | 432 | 1021 | 48 | 2.2k | |
| Osamu Nemoto | 865 | 420 | 296 | 539 | 53 | 1.9k | |
| Takafumi Etoh | 1115 | 658 | 458 | 728 | 55 | 2.0k | |
| Wolfgang Czech | 716 | 699 | 645 | 705 | 45 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...